Matt Herper on the FDA's Avandia Data Desert

by: |
07/27/2007

http://www.forbes.com/business/2007/07/26/glaxo-avandia-fda-biz-cx_mh_0726glaxo.html

Or why the blockbuster model of drug development and data collection is over.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Matt Herper on the FDA's Avandia Data Desert

Latest from CMPI

Coronavirus: America’s drug supply needs a refill

Prescription for Failure: The Ills of Socialized Medicine (CPAC 2020)

How to eliminate surprise medical bills

Keep Canadian drugs out of U.S. medicine cabinets

Blog Roll

Categories